Olaparib combined with abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A randomized phase II trial.
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5003-5003
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS193-TPS193
2019 ◽
Vol 17
(4)
◽
pp. 241-247.e1
◽
2012 ◽
Vol 10
(1)
◽
pp. 6-14
◽
2010 ◽
Vol 29
(6)
◽
pp. 1432-1440
◽
2015 ◽
Vol 21
(17)
◽
pp. 3862-3869
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4684-4684